As on Wednesday, SELLAS Life Sciences Group Inc (NASDAQ: SLS) got off with the flyer as it spiked 4.00% to $2.08, before settling in for the price of $2.0 at the close. Taking a more long-term approach, SLS posted a 52-week range of $0.77-$2.48.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 45.94%. Meanwhile, its Annual Earning per share during the time was 45.94%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 41.33%. This publicly-traded company’s shares outstanding now amounts to $125.08 million, simultaneously with a float of $122.48 million. The organization now has a market capitalization sitting at $260.16 million. At the time of writing, stock’s 50-day Moving Average stood at $1.85, while the 200-day Moving Average is $1.57.
SELLAS Life Sciences Group Inc (SLS) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. SELLAS Life Sciences Group Inc’s current insider ownership accounts for 2.08%, in contrast to 21.56% institutional ownership. According to the most recent insider trade that took place on Jun 12 ’25, this organization’s Director bought 10,000 shares at the rate of 1.48, making the entire transaction reach 14,800 in total value, affecting insider ownership by 20,400. Preceding that transaction, on May 30 ’25, Company’s Director bought 20,000 for 1.69, making the whole transaction’s value amount to 33,800. This particular insider is now the holder of 30,400 in total.
SELLAS Life Sciences Group Inc (SLS) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
SELLAS Life Sciences Group Inc’s EPS increase for this current 12-month fiscal period is 41.33% and is forecasted to reach -0.36 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 20.63% through the next 5 years, which can be compared against the 45.94% growth it accomplished over the previous five years trading on the market.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
Let’s observe the current performance indicators for SELLAS Life Sciences Group Inc (SLS). It’s Quick Ratio in the last reported quarter now stands at 4.91.
In the same vein, SLS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.33, a figure that is expected to reach -0.08 in the next quarter, and analysts are predicting that it will be -0.36 at the market close of one year from today.
Technical Analysis of SELLAS Life Sciences Group Inc (SLS)
Through scrutinizing the latest numbers posted by the [SELLAS Life Sciences Group Inc, SLS], it can be observed that its last 5-days Average volume of 4.31 million was better the volume of 2.74 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 24.87% While, its Average True Range was 61.62.
Raw Stochastic average of SELLAS Life Sciences Group Inc (SLS) in the period of the previous 100 days is set at 60.40%, which indicates a major rise in contrast to 36.51% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.18 that was higher than 0.13 volatility it exhibited in the past 100-days period.
